PANews reported on March 11 that, according to Globenewswire, YZi Labs issued a statement saying that, according to a lawsuit filed by investor Abraham Gomez againstPANews reported on March 11 that, according to Globenewswire, YZi Labs issued a statement saying that, according to a lawsuit filed by investor Abraham Gomez against

YZi Labs demands CEA Industries address the "operational vacuum" issue and terminate the 10X asset management agreement.

2026/03/11 20:48
1 min read
For feedback or concerns regarding this content, please contact us at [email protected]

PANews reported on March 11 that, according to Globenewswire, YZi Labs issued a statement saying that, according to a lawsuit filed by investor Abraham Gomez against Nasdaq-listed CEA Industries and its director Hans Thomas, the company is practically in an "operational vacuum," lacking a CFO, COO, operations or marketing teams, a fund management system, and even a registered domain name or a working website. YZi Labs argues that this situation highlights the failure of CEA Industries' board oversight and the company's failure to establish basic corporate governance and operational infrastructure while managing substantial funds under a 20-year asset management agreement with 10X Capital Asset Management. Therefore, YZi Labs is demanding that the board publicly respond to the allegations, establish an independent committee to investigate Hans Thomas, and terminate the agreement with 10X Capital Asset Management.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.